U.K. researchers announced Thursday that the immune suppressant baricitinib reduced the risk of dying among hospitalized COVID-19 patients by 13%.
Share this post
Rheumatoid arthritis drug could be lifesaver…
Share this post
U.K. researchers announced Thursday that the immune suppressant baricitinib reduced the risk of dying among hospitalized COVID-19 patients by 13%.